Dabur India's Dadra Plant Red-Flagged by US FDA Over Contamination, Falsified Records
The US FDA cited Dabur India's Dadra and Nagar Haveli facility for microbiological contamination risks, equipment maintenance lapses, falsified manufacturing records, and a live bird found in a raw material warehouse. The flags raise compliance concerns for the company's US-bound Ayurvedic and OTC healthcare exports.
What happened
US FDA flagged Dabur India's Dadra and Nagar Haveli plant for microbiological contamination risks, equipment maintenance lapses, falsified manufacturing
Why this matters
Reassess US distribution partnerships and contract manufacturing alternatives for Ayurvedic and OTC lines, and evaluate whether acquiring an FDA-compliant facility or co-manufacturer could de-risk the export pipeline during remediation.